U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LC-1004-002
Preferred Name English
INCLACUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Inclacumab [WHO-DD]
Common Name English
inclacumab [INN]
Common Name English
RG-1512
Code English
INCLACUMAB [USAN]
Common Name English
RG1512
Code English
RO-4905417
Code English
LC1004-002
Code English
RO4905417
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 875522
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
Code System Code Type Description
USAN
ZZ-135
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
INN
9512
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
CAS
1256258-86-2
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
WIKIPEDIA
Inclacumab
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109487
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
DRUG BANK
DB12246
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
NCI_THESAURUS
C174603
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109650
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
FDA UNII
A6734I702L
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
SMS_ID
100000174937
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109488
Created by admin on Mon Mar 31 20:58:28 GMT 2025 , Edited by admin on Mon Mar 31 20:58:28 GMT 2025
PRIMARY
ACTIVE MOIETY
INCLACUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966